476 related articles for article (PubMed ID: 20651219)
21. Relative contributions of emphysema and airway remodelling to airflow limitation in COPD: Consistent results from two cohorts.
Tho NV; Ryujin Y; Ogawa E; Trang le TH; Kanda R; Goto K; Yamaguchi M; Nagao T; Lan le TT; Nakano Y
Respirology; 2015 May; 20(4):594-601. PubMed ID: 25788016
[TBL] [Abstract][Full Text] [Related]
22. Influence of Emphysema and Air Trapping Heterogeneity on Pulmonary Function in Patients with COPD.
Li K; Gao Y; Pan Z; Jia X; Yan Y; Min X; Huang K; Jiang T
Int J Chron Obstruct Pulmon Dis; 2019; 14():2863-2872. PubMed ID: 31839706
[TBL] [Abstract][Full Text] [Related]
23. Computed tomography assessment of pharmacological lung volume reduction induced by bronchodilators in COPD.
Tanabe N; Muro S; Oguma T; Sato S; Kiyokawa H; Takahashi T; Kudo M; Kinose D; Kubo T; Hoshino Y; Ogawa E; Hirai T; Mishima M
COPD; 2012 Aug; 9(4):401-8. PubMed ID: 22509949
[TBL] [Abstract][Full Text] [Related]
24. Airway distensibility in adults with asthma and healthy adults, measured by forced oscillation technique.
Brown NJ; Salome CM; Berend N; Thorpe CW; King GG
Am J Respir Crit Care Med; 2007 Jul; 176(2):129-37. PubMed ID: 17463413
[TBL] [Abstract][Full Text] [Related]
25. On the Potential Role of MRI Biomarkers of COPD to Guide Bronchoscopic Lung Volume Reduction.
Adams CJ; Capaldi DPI; Di Cesare R; McCormack DG; Parraga G;
Acad Radiol; 2018 Feb; 25(2):159-168. PubMed ID: 29051040
[TBL] [Abstract][Full Text] [Related]
26. The extent of emphysema in patients with COPD.
Shaker SB; Stavngaard T; Hestad M; Bach KS; Tonnesen P; Dirksen A
Clin Respir J; 2009 Jan; 3(1):15-21. PubMed ID: 20298367
[TBL] [Abstract][Full Text] [Related]
27. A novel CT-emphysema index/FEV
Loh LC; Ong CK; Koo HJ; Lee SM; Lee JS; Oh YM; Seo JB; Lee SD
Int J Chron Obstruct Pulmon Dis; 2018; 13():2543-2550. PubMed ID: 30174423
[TBL] [Abstract][Full Text] [Related]
28. Lobe-based computed tomography assessment of airway diameter, airway or vessel number, and emphysema extent in relation to the clinical outcomes of COPD.
Kurashima K; Takaku Y; Hoshi T; Kanauchi T; Nakamoto K; Takayanagi N; Yanagisawa T; Sugita Y; Kawabata Y
Int J Chron Obstruct Pulmon Dis; 2015; 10():1027-33. PubMed ID: 26082626
[TBL] [Abstract][Full Text] [Related]
29. Pulmonary function and sputum characteristics predict computed tomography phenotype and severity of COPD.
Camiciottoli G; Bigazzi F; Paoletti M; Cestelli L; Lavorini F; Pistolesi M
Eur Respir J; 2013 Sep; 42(3):626-35. PubMed ID: 23258785
[TBL] [Abstract][Full Text] [Related]
30. Is intrathoracic tracheal collapsibility correlated to clinical phenotypes and sex in patients with COPD?
Camiciottoli G; Diciotti S; Bigazzi F; Lombardo S; Bartolucci M; Paoletti M; Mascalchi M; Pistolesi M
Int J Chron Obstruct Pulmon Dis; 2015; 10():843-52. PubMed ID: 25960647
[TBL] [Abstract][Full Text] [Related]
31. Lung dysfunction of chronic smokers with no signs of COPD.
Nagelmann A; Tonnov Ä; Laks T; Sepper R; Prikk K
COPD; 2011 Jun; 8(3):189-95. PubMed ID: 21513442
[TBL] [Abstract][Full Text] [Related]
32. Phenotype/endotype-driven therapy in COPD: potential economic implications.
Antoniu SA
Expert Rev Pharmacoecon Outcomes Res; 2013 Aug; 13(4):421-3. PubMed ID: 23977968
[No Abstract] [Full Text] [Related]
33. Relationship between plasma matrix metalloproteinase levels, pulmonary function, bronchodilator response, and emphysema severity.
Koo HK; Hong Y; Lim MN; Yim JJ; Kim WJ
Int J Chron Obstruct Pulmon Dis; 2016; 11():1129-37. PubMed ID: 27313452
[TBL] [Abstract][Full Text] [Related]
34. Hyperpolarized (3)He ventilation defects used to predict pulmonary exacerbations in mild to moderate chronic obstructive pulmonary disease.
Kirby M; Pike D; Coxson HO; McCormack DG; Parraga G
Radiology; 2014 Dec; 273(3):887-96. PubMed ID: 24960283
[TBL] [Abstract][Full Text] [Related]
35. Gender differences in the severity of CT emphysema in COPD.
Dransfield MT; Washko GR; Foreman MG; Estepar RS; Reilly J; Bailey WC
Chest; 2007 Aug; 132(2):464-70. PubMed ID: 17573503
[TBL] [Abstract][Full Text] [Related]
36. CT metrics of airway disease and emphysema in severe COPD.
Kim WJ; Silverman EK; Hoffman E; Criner GJ; Mosenifar Z; Sciurba FC; Make BJ; Carey V; San José Estépar R; Diaz A; Reilly JJ; Martinez FJ; Washko GR;
Chest; 2009 Aug; 136(2):396-404. PubMed ID: 19411295
[TBL] [Abstract][Full Text] [Related]
37. Effect of obesity on respiratory mechanics during rest and exercise in COPD.
Ora J; Laveneziana P; Wadell K; Preston M; Webb KA; O'Donnell DE
J Appl Physiol (1985); 2011 Jul; 111(1):10-9. PubMed ID: 21350021
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms for isolated volume response to a bronchodilator in patients with COPD.
Cerveri I; Pellegrino R; Dore R; Corsico A; Fulgoni P; van de Woestijne KP; Brusasco V
J Appl Physiol (1985); 2000 Jun; 88(6):1989-95. PubMed ID: 10846010
[TBL] [Abstract][Full Text] [Related]
39. Relationship Between Emphysema Severity and the Location of Lung Cancer in Patients With Chronic Obstructive Lung Disease.
Lim J; Shin KM; Lee K; Lim JK; Kim HJ; Cho SH; Cha SI
AJR Am J Roentgenol; 2015 Sep; 205(3):540-5. PubMed ID: 26295639
[TBL] [Abstract][Full Text] [Related]
40. Tidal expiratory flow limitation at rest as a functional marker of pulmonary emphysema in moderate-to-severe COPD.
Chiari S; Bassini S; Braghini A; Corda L; Boni E; Tantucci C
COPD; 2014 Feb; 11(1):33-8. PubMed ID: 24102405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
